Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Giovanna Margagnoni"'
Publikováno v:
Endoscopy. 53:E79-E80
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edf1f2aff383b70d930d17f5d5f4186f
https://doi.org/10.1055/a-1196-1095
https://doi.org/10.1055/a-1196-1095
Publikováno v:
Scopus-Elsevier
Even though the exact amount of the increased risk is not known, patients with Ulcerative Colitis (UC) are more likely to develop colonic malignancy compared with the general population. 5-aminosalicilic acid (5-ASA) compounds are the mainstay therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fd05bccda88ca2b93ddb87144572211
https://doi.org/10.2174/1574884708666131111202337
https://doi.org/10.2174/1574884708666131111202337
Autor:
Federica Fascì-Spurio, Vito Annese, Giovanna Margagnoni, Claudio Papi, Francesca Rogai, Alessia Settesoldi
Publikováno v:
Digestive and Liver Disease. 45:978-985
In recent years mucosal healing has emerged as an important therapeutic goal for patients with inflammatory bowel disease. Growing evidence suggests that achieving mucosal healing can improve patient outcomes and, potentially, alter the course of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f417045fabc2a91ed1fc437cf674898
https://doi.org/10.1016/j.dld.2013.07.006
https://doi.org/10.1016/j.dld.2013.07.006
Autor:
R. Monterubbianesi, Marco Vincenzo Lenti, Gino Roberto Corazza, Laura Cantoro, Antonio Di Sabatino, Diana Giannarelli, Giovanna Margagnoni, Anna Kohn, Alessandro Massari, Sandro Ardizzone, Claudio Papi, Paolo Giuffrida
Publikováno v:
Journal of Crohn'scolitis. 11(8)
Inflammatory bowel disease [IBD] patients are still under-diagnosed or diagnosed with serious delay. We examined whether diagnostic delay [DD] in IBD has changed over the last 60 years, and explored the risk factors of longer DD.In total, 3392 IBD pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d1492c857611994797ffa7857a7ff4
https://pubmed.ncbi.nlm.nih.gov/28333328
https://pubmed.ncbi.nlm.nih.gov/28333328
Autor:
Vito D. Corleto, Stefano Angeletti, Emilio Di Giulio, Giancarlo D'Ambra, Giovanna Margagnoni, Cristiano Pagnini, M. Ruggeri
Background Large colorectal superficial neoplastic lesions are challenging to remove. This study aimed to assess the outcomes of routine endoscopic resection of large (≥2 cm and Methods From 4587 endoscopic resections, 265 (5.7%) large and giant le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84be3d414c5fe6a45ca5f4d9c74e5875
http://hdl.handle.net/11573/934368
http://hdl.handle.net/11573/934368
Publikováno v:
Reviews on Recent Clinical Trials. 7:307-313
Most patients with Crohn's disease will require surgery during the course of their disease. However, surgery is not curative and post-operative recurrence is quite inexorable. One year after resection up to 80% of patients have new lesions at the neo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1b957549bf6305ecad547e60128c7b7
https://doi.org/10.2174/1574887111207040307
https://doi.org/10.2174/1574887111207040307
Autor:
Giovanna Margagnoni, Claudio Papi, Annalisa Aratari, Maria Teresa Doddato, Francesca Chiesara, Federica Fascì Spurio
Publikováno v:
Current Clinical Pharmacology. 7:131-136
Crohn's disease and ulcerative colitis are inflammatory bowel diseases characterised by a chronic relapsing course. Corticosteroids represent the mainstay of medical treatment of inflammatory bowel disease for the induction of remission. Despite the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4073362f475cce3fd567d47c136c48aa
https://doi.org/10.2174/157488412800228875
https://doi.org/10.2174/157488412800228875
Publikováno v:
Recenti progressi in medicina. 106(11)
In the last years the therapeutic goals of inflammatory bowel disease have changed from control of symptoms only towards long term strategies aimed at modifying the natural history of the disease. In this setting mucosal healing has emerged as an imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19562247da2e36f33098ee26a63ad896
https://pubmed.ncbi.nlm.nih.gov/26668042
https://pubmed.ncbi.nlm.nih.gov/26668042
Publikováno v:
Recenti progressi in medicina. 105(12)
Identify environmental factors that can influence the course of inflammatory bowel disease (IBD) is of great interest since managing on these factors might improve the prognosis of patients. No environmental factor has been shown to have a linear cau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4fef61f5ada5ac3706d12f2c535a4c13
https://pubmed.ncbi.nlm.nih.gov/25533236
https://pubmed.ncbi.nlm.nih.gov/25533236
Autor:
Federica, Fasci Spurio, Annalisa, Aratari, Giovanna, Margagnoni, Valeria, Clemente, Alessandra, Moretti, Claudio, Papi
Systemic corticosteroids have been used to treat active inflammatory bowel disease for over 50 years by virtue of their unquestionable efficacy in inducing clinical remission rapidly in the vast majority of patients. Nevertheless, traditional cortico
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::56a4028c64610c0bc2160debb6894453
http://hdl.handle.net/11573/540341
http://hdl.handle.net/11573/540341